Literature DB >> 16401747

Sympathomimetic-induced kaleidoscopic visual illusion associated with a reversible splenium lesion.

Heather Winslow1, Bruce Mickey, Elliot M Frohman.   

Abstract

BACKGROUND: Sympathomimetic-induced metabolic derangements within the central nervous system can result in conspicuous changes in neurological functioning and corresponding radiographic abnormalities that can be reversible.
OBJECTIVE: To describe a patient with a "kaleidoscopic" visual illusion who was found by magnetic resonance imaging to have a transient lesion in the splenium of the corpus callosum.
DESIGN: Case report.
SETTING: The University of Texas Southwestern Medical Center, Dallas. PATIENT: A 17-year-old adolescent girl who developed an episode of kaleidoscopic vision while using sympathomimetic-containing diet pills that was associated with a reversible lesion of the splenium of the corpus callosum. Her brother has a history of migraine and experienced a similar episode while using illicit stimulant agents. INTERVENTION: Withdrawal of the medication resulted in the cessation of the episodes and normalization of the magnetic resonance image. MAIN OUTCOME MEASURES: Clinical and radiographic improvement.
RESULTS: Sympathomimetic-induced metabolic derangements can be associated with reversible lesions within the brain.
CONCLUSIONS: We hypothesize that the visual fragmentation was a manifestation of a migraine triggered by sympathomimetic-containing diet pills, and that the transient lesion in the corpus callosum was a manifestation of a reversible metabolic derangement. Both the visual fragmentation and the lesion in the corpus callosum resolved once the patient stopped receiving diet pills.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16401747     DOI: 10.1001/archneur.63.1.135

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  7 in total

1.  Reversible splenial lesion and complex visual disturbances due to carbamazepine withdrawal.

Authors:  Rosa Cortese; Giuseppe Pontrelli; Maria Paola Mogavero; Franca Dicuonzo; Carla Tortorella
Journal:  Neurol Sci       Date:  2015-03-13       Impact factor: 3.307

2.  Reversible splenial abnormality in hypoglycemic encephalopathy.

Authors:  Ji Hyun Kim; Jeong Yoon Choi; Seong-Beom Koh; Younghen Lee
Journal:  Neuroradiology       Date:  2006-11-30       Impact factor: 2.804

Review 3.  Reversible focal splenial lesions.

Authors:  Massimo Gallucci; Nicola Limbucci; Amalia Paonessa; Ferdinando Caranci
Journal:  Neuroradiology       Date:  2007-05-24       Impact factor: 2.804

4.  Reversible Splenial Lesion Syndrome with Some Novel Causes and Clinical Manifestations.

Authors:  Pei-Lin Lu; John F Hodes; Xu Zheng; Xing-Yue Hu
Journal:  Intern Med       Date:  2020-06-30       Impact factor: 1.271

5.  Altered white matter integrity in patients with monocular blindness: A diffusion tensor imaging and tract-based spatial statistics study.

Authors:  Yu-Xin Liu; Biao Li; Kang-Rui Wu; Li-Ying Tang; Qi Lin; Qing-Hai Li; Qing Yuan; Wen-Qing Shi; Rong-Bin Liang; Qian-Min Ge; Yi Shao
Journal:  Brain Behav       Date:  2020-06-17       Impact factor: 2.708

6.  Transient and reversible focal lesion involving the splenium of the corpus callosum in a person with epilepsy.

Authors:  Nitin C Parikh; Makarand Kulkarni
Journal:  Ann Indian Acad Neurol       Date:  2008-04       Impact factor: 1.383

7.  Unusual combination of reversible splenial lesion and meningitis-retention syndrome in aseptic meningomyelitis.

Authors:  Nida Tascilar; Hande Aydemir; Ufuk Emre; Aysun Unal; H Tugrul Atasoy; Sureyya Ekem
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.